Homozygous Familial Hypercholesterolaemia: Summary for Cardiologists Source: European Atherosclerosis Society; Medically Reviewed by Dr Shouvik Haldar

https://reference.medscape.com/cc2/p10/guideline-essentials-2023-eas-recommendations-homozygous-2023a1000je9?ecd=WNL_drugguide_260204_MSCPREF_endo_etid8076742&uac=148436CN&impID=8076742#1 In 2023, the European Atherosclerosis Society (EAS) published a comprehensive update to its 2014 statement on homozygous familial hypercholesterolaemia (HoFH). The new guidance covers recent advances in genetics and treatments, and addresses the practical realities of care in different countries. This specialist Medscape overview for UK cardiologists covers case finding, diagnosis, cardiovascular assessment, treatment, and family planning. Please refer to the full guideline for all of the recommendations.